Radiotherapy and Oncology


Publication Venue For

  • A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma.  157:203-209. 2021
  • The role of computational methods for automating and improving clinical target volume definition.  153:15-25. 2020
  • Dose–volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: A cross-sectional dosimetric analysis.  149:142-149. 2020
  • Precision toxicity correlates of tumor spatial proximity to organs at risk in cancer patients receiving intensity-modulated radiotherapy.  148:245-251. 2020
  • Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery.  142:168-174. 2020
  • Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.  135:58-64. 2019
  • Fatigue following radiation therapy in nasopharyngeal cancer survivors: A dosimetric analysis incorporating patient report and observer rating.  133:35-42. 2019
  • Radiotherapy dose–volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.  128:442-451. 2018
  • Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.  124:248-255. 2017
  • Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis.  123:1-9. 2017
  • EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: A secondary analysis of RTOG 0324.  112:30-36. 2014
  • Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.  111:468-474. 2014
  • Kinomic profiling approach identifies Trk as a novel radiation modulator.  103:380-387. 2012
  • Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.  101:183-189. 2011
  • Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma.  99:339-343. 2011
  • The poly(ADP-ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.  99:331-338. 2011
  • Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma.  92:339-344. 2009
  • Radiation dose, driving performance, and cognitive function in patients with head and neck cancer.  87:304-307. 2008
  • Radiotherapy for the treatment of primary vaginal cancer.  77:133-136. 2005
  • Conventional four-field pelvic radiotherapy technique without CT treatment planning in cancer of the cervix: potential geographic miss.  30:140-145. 1994
  • Effect of backscatter on cell survival for a clinical electron beam.  21:269-272. 1991
  • Isolated local-regional recurrence following mastectomy for adenocarcinoma of the breast treated with radiation therapy alone or combined with surgery and/or chemotherapy.  12:177-185. 1988
  • International Standard Serial Number (issn)

  • 0167-8140
  • Electronic International Standard Serial Number (eissn)

  • 1879-0887